These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 10727589

  • 1. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
    Lai HC, FitzSimmons SC, Allen DB, Kosorok MR, Rosenstein BJ, Campbell PW, Farrell PM.
    N Engl J Med; 2000 Mar 23; 342(12):851-9. PubMed ID: 10727589
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D, Grasemann C, Staab D, Wollmann H, Ratjen F, German Cystic Fibrosis Growth Hormone Study Group.
    Pediatrics; 2007 Jun 23; 119(6):e1230-8. PubMed ID: 17545356
    [Abstract] [Full Text] [Related]

  • 3. Delayed pubertal growth spurt in glomerulopathic boys receiving alternate-day prednisone.
    Polito C, Di Toro R.
    Child Nephrol Urol; 1992 Jun 23; 12(4):202-7. PubMed ID: 1473093
    [Abstract] [Full Text] [Related]

  • 4. Growth in children with chronic lung disease.
    Davis PB, Kercsmar CM.
    N Engl J Med; 2000 Mar 23; 342(12):887-8. PubMed ID: 10727595
    [No Abstract] [Full Text] [Related]

  • 5. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA, Hanauer SB, Kirschner BS.
    J Pediatr Gastroenterol Nutr; 2007 Sep 23; 45(3):312-8. PubMed ID: 17873743
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
    Zemel BS, Jawad AF, FitzSimmons S, Stallings VA.
    J Pediatr; 2000 Sep 23; 137(3):374-80. PubMed ID: 10969263
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
    Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, Cutler GB.
    N Engl J Med; 2003 Mar 06; 348(10):908-17. PubMed ID: 12621135
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
    Simmonds J, Grundy N, Trompeter R, Tullus K.
    Arch Dis Child; 2010 Feb 06; 95(2):146-9. PubMed ID: 20172895
    [Abstract] [Full Text] [Related]

  • 11. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A, United Kingdom Cystic Fibrosis Database Steering Committee.
    Pediatrics; 2007 Jan 06; 119(1):19-28. PubMed ID: 17200267
    [Abstract] [Full Text] [Related]

  • 12. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.
    Simon D, Fernando C, Czernichow P, Prieur AM.
    J Rheumatol; 2002 Jun 06; 29(6):1296-300. PubMed ID: 12064849
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth in 10- to 12-year-old children born at 23 to 25 weeks' gestation in the 1990s: a Swedish national prospective follow-up study.
    Farooqi A, Hägglöf B, Sedin G, Gothefors L, Serenius F.
    Pediatrics; 2006 Nov 06; 118(5):e1452-65. PubMed ID: 17079546
    [Abstract] [Full Text] [Related]

  • 15. Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group.
    Hintz RL, Attie KM, Baptista J, Roche A.
    N Engl J Med; 1999 Feb 18; 340(7):502-7. PubMed ID: 10021470
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group.
    Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV.
    J Pediatr; 1995 Apr 18; 126(4):515-23. PubMed ID: 7699528
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma.
    Schuh S, Reisman J, Alshehri M, Dupuis A, Corey M, Arseneault R, Alothman G, Tennis O, Canny G.
    N Engl J Med; 2000 Sep 07; 343(10):689-94. PubMed ID: 10974132
    [Abstract] [Full Text] [Related]

  • 20. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ, Lee J, Nardelli N, Julian BA, Cattran D, Waldo B, Wyatt R, Jennette JC, Sibley R, Hyland K, Fitzgibbons L, Hirschman G, Donadio JV, Holub BJ, Southwest Pediatric Nephrology Study Group.
    Clin J Am Soc Nephrol; 2006 May 07; 1(3):467-74. PubMed ID: 17699247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.